• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THE SPECTRANETICS CORPORATION SPECTRANETICS LEAD LOCKING DEVICE; STYLET, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THE SPECTRANETICS CORPORATION SPECTRANETICS LEAD LOCKING DEVICE; STYLET, CATHETER Back to Search Results
Model Number 518-062
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cardiac Perforation (2513); Device Embedded In Tissue or Plaque (3165); Pericardial Effusion (3271)
Event Date 10/13/2022
Event Type  Injury  
Event Description
A lead extraction procedure commenced to remove a right atrial (ra), a right ventricular (rv) and a left ventricular (lv) lead due to non function.The patient had a baseline pericardial effusion present pre-procedure.Spectranetics lead locking devices (llds) were inserted into each lead to provide traction.Multiple spectranetics devices (11f tightrail sub-c rotating dilator sheath, 13f tightrail rotating dilator sheath, glidelight laser sheath) were used to extract the ra and rv leads.The rv lead was firmly adhered within the vessel; however, the ra and rv leads were successfully removed.During attempted extraction of the lv lead, several attempts were made but were unsuccessful.The physician elected to cut the lv lead/lld near the pocket and abandoned it, with no attempt to unlock the lld from the lead.A short time after the lead extraction portion of the procedure was completed, the baseline pericardial effusion worsened and cardiac tamponade resulted.Rescue efforts began, including pericardiocentesis, and the patient stabilized without further accumulation of fluid throughout the remainder of the case.A re-implantation of new ra, rv, and lv leads was completed, and the patient was transferred to the post anesthesia care unit (pacu).Later, the patient had a cardiac arrest that resolved with continuous aspiration of pericardial fluid.Patient was returned to the operating room, and labs showed an acute and severe coagulopathy.A sternotomy was performed and three perforations were discovered: a 2 cm longitudinal perforation on the posterior aspect of the innominate vein (mdr #1721279-2022-00190), a small perforation in the right atrium (mdr #1721279-2022-00191), and a perforation to the obtuse margin, near the coronary sinus the distal tip of the lv lead was noted to be extruding from a coronary vein (near the coronary sinus, observed outside the heart wall); the lv lead was firmly adhered to the vein, just proximal to the lv lead''s distal tip.Repairs to the perforations were completed; however, the patient could not be weaned off the pump and the decision was made to implement a do not resuscitate (dnr) order and the patient expired.This report captures the lld providing traction to the lv lead, which was initially cut and capped, and later an obtuse margin perforation was discovered, requiring intervention.There was no alleged malfunction of any spectranetics devices in use during the procedure.Although the patient died, the death is captured in mdr #1721279-2022-00190.
 
Manufacturer Narrative
Device evaluated by mfr: a portion of the device was discarded and a portion remained in the patient, thus no investigation could be completed.Although lld cut/cap within a lead is a known risk of complication with use of the lld, the physician did not attempt to unlock the lld from the ra lead prior to cutting and capping it.In addition, the subsequent cardiac perforation that was discovered is a known risk of complication with use of the lld.Submission of this report does not, in itself, represent a conclusion by the manufacturer and/or authorized representative or the national competent authority that the content of this report is complete or accurate, that the medical device(s) listed failed in any manner and/or that the medical device(s) caused or contributed to an alleged death or deterioration in the state of the health of any person.Reason for edit update.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRANETICS LEAD LOCKING DEVICE
Type of Device
STYLET, CATHETER
Manufacturer (Section D)
THE SPECTRANETICS CORPORATION
9965 federal drive
colorado springs CO 80921
Manufacturer (Section G)
SPECTRANETICS
9965 federal drive
colorado springs CO 80921
Manufacturer Contact
barbara creel
9965 federal drive
colorado springs, CO 80921
MDR Report Key15764665
MDR Text Key303395075
Report Number1721279-2022-00192
Device Sequence Number1
Product Code DRB
UDI-Device Identifier00813132023072
UDI-Public00813132023072
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K142116
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 11/09/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/09/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number518-062
Device Catalogue Number518-062
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received10/13/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
ABBOTT 1156T LV LEAD; ABBOTT 1888TC RA PACING LEAD; ABBOTT 7121Q RV ICD LEAD; SPECTRANETICS 11F TIGHTRAIL SUB-C DILATOR SHEATH; SPECTRANETICS 13F TIGHTRAIL DILATOR SHEATH; SPECTRANETICS CVX-300 EXCIMER LASER SYSTEM; SPECTRANETICS GLIDELIGHT LASER SHEATH; SPECTRANETICS LEAD LOCKING DEVICES
Patient Outcome(s) Other; Required Intervention; Life Threatening;
Patient Age77 YR
Patient SexFemale
-
-